Harrow Health, Inc. (HROW) stock price, financials & research | GoAI

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

61/ 100

GoAI Score

Buy

Valuation

79

Undervalued

Sentiment

69

Bullish

Risk

44

Elevated Risk

Momentum

46

Neutral

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Headquarters: US

Market position

Day range

Current $29.36

$27.00$30.90

52-week range

Current $29.36

$27.00$54.85

Open: $30.73
Previous close: $30.52
Volume: 1.35M
Market cap: 1.09B USD
50-day average: $36.2948; -19.11% below average
200-day average: $39.961; -26.53% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM): -29.58×
P/B (TTM): 72.15×
P/S (TTM): 3.97×
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 73.28%
Operating margin: 2.07%
Net margin: -13.51%

Financial health

Debt / equity: 19.79×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

272.3M USD+36.41%

Operating income

38.61M USD+337.64%

Net income

−5.14M USD+70.60%

Financial statements: Income statement
Metric (USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	272.3M USD	199.61M USD	130.19M USD	88.6M USD	72.48M USD
Cost of goods sold	67.93M USD	49.25M USD	39.64M USD	25.38M USD	18.21M USD
Gross profit	204.37M USD	150.37M USD	90.55M USD	63.21M USD	54.26M USD
Research and development	12.85M USD	12.23M USD	6.65M USD	3.05M USD	11.08M USD
Selling, general, and administrative	152.91M USD	—	—	—	39.82M USD
Operating expenses	165.76M USD	141.55M USD	90.12M USD	61.29M USD	52.65M USD
Interest expense	24.18M USD	22.79M USD	21.32M USD	7.24M USD	5.44M USD
Depreciation and amortization	19.68M USD	14.54M USD	12.34M USD	3.67M USD	2.4M USD
Operating income	38.61M USD	8.82M USD	431K USD	1.92M USD	1.61M USD
Net income	−5.14M USD	−17.48M USD	−24.41M USD	−14.09M USD	−18.01M USD

Company facts updated Oct 11, 2026.

Earnings

EPS beat rate: 27%; 3 beats, 8 misses, 0 met estimates
Average EPS surprise: -155.71%; 11 comparable reports
Latest EPS result: -0.46; Estimate -0.18 · Miss by 157.34%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

10 ratings

Strong buy00%

Buy10100%

Hold00%

Sell00%

Strong sell00%

Recent analyst actions

7 institutions

Ladenburg ThalmannmaintainBuyNov 12, 2025

HROW peers

Amgen Inc.

AMGN

Amgen Inc.

$414.87

+1.82%

Gilead Sciences, Inc.

GILD

Gilead Sciences, Inc.

$151.17

+2.77%

Intuitive Surgical, Inc.

ISRG

Intuitive Surgical, Inc.

$423.96

+2.06%

Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

$510.08

+1.36%

Sanofi

SNY

Sanofi

$40.07

-0.40%

Moderna, Inc.

MRNA

Moderna, Inc.

$225

+14.21%

ETFs holding HROW

Funds reporting this stock among their holdings, ordered by reported position size.

ETFMarket valueWeightAUMExpense ratioPrice / 1D

Vanguard Morningstar Total Stock Market ETF

Vanguard Morningstar Total Stock Market ETFVTI36.96M0.00%2.3T USD0.03%$381.94+0.63%

iShares Russell 2000 ETF

iShares Russell 2000 ETFIWM25.97M0.03%78.74B USD0.19%$278.94+0.49%

Vanguard Extended Market ETF

Vanguard Extended Market ETFVXF14.22M0.01%95.4B USD0.05%$235+0.80%

iShares Russell 2000 Growth ETF

iShares Russell 2000 Growth ETFIWO9.08M0.07%13.92B USD0.24%$356.78+0.94%

Dimensional - US Small Cap ETF

Dimensional - US Small Cap ETFDFAS8.38M0.02%33.87B USD0.31%$78.35+0.32%

State Street SPDR S&P Pharmaceuticals ETF

State Street SPDR S&P Pharmaceuticals ETFXPH7.62M1.65%461.57M USD0.35%$64.65+1.60%

Vanguard Russell 2000 ETF

Vanguard Russell 2000 ETFVTWO6.87M0.04%18B USD0.06%$112.66+0.50%

Fidelity Enhanced Small Cap ETF

Fidelity Enhanced Small Cap ETFFESM5.66M0.09%6.41B USD0.28%$45.46+0.46%

Vanguard Morningstar Total Stock Market ETF

Vanguard Morningstar Total Stock Market ETFVTI

Market value: 36.96M
Weight: 0.00%
AUM: 2.3T USD
Expense ratio: 0.03%
Price / 1D: $381.94+0.63%

iShares Russell 2000 ETF

iShares Russell 2000 ETFIWM

Market value: 25.97M
Weight: 0.03%
AUM: 78.74B USD
Expense ratio: 0.19%
Price / 1D: $278.94+0.49%

Vanguard Extended Market ETF

Vanguard Extended Market ETFVXF

Market value: 14.22M
Weight: 0.01%
AUM: 95.4B USD
Expense ratio: 0.05%
Price / 1D: $235+0.80%

iShares Russell 2000 Growth ETF

iShares Russell 2000 Growth ETFIWO

Market value: 9.08M
Weight: 0.07%
AUM: 13.92B USD
Expense ratio: 0.24%
Price / 1D: $356.78+0.94%

Dimensional - US Small Cap ETF

Dimensional - US Small Cap ETFDFAS

Market value: 8.38M
Weight: 0.02%
AUM: 33.87B USD
Expense ratio: 0.31%
Price / 1D: $78.35+0.32%

State Street SPDR S&P Pharmaceuticals ETF

State Street SPDR S&P Pharmaceuticals ETFXPH

Market value: 7.62M
Weight: 1.65%
AUM: 461.57M USD
Expense ratio: 0.35%
Price / 1D: $64.65+1.60%

Vanguard Russell 2000 ETF

Vanguard Russell 2000 ETFVTWO

Market value: 6.87M
Weight: 0.04%
AUM: 18B USD
Expense ratio: 0.06%
Price / 1D: $112.66+0.50%

Fidelity Enhanced Small Cap ETF

Fidelity Enhanced Small Cap ETFFESM

Market value: 5.66M
Weight: 0.09%
AUM: 6.41B USD
Expense ratio: 0.28%
Price / 1D: $45.46+0.46%

Continue in GoAI

AI-generated and delayed market data for informational and educational purposes only. Not investment advice.